$VIR news
The latest VIR stock news: headlines, filings, AI summaries and sentiment for $VIR, updated around the clock.
- DOJ Investigates Megaspeed Amid Nvidia Espionage Concerns
- Vir Biotechnology, Inc. - 8-K Filing
- Stock Market Overview: Mixed Futures Amid Tech Recovery and Inflation Anticipation
- Vir Biotechnology Reports Positive Phase 3 Trial Results for Chronic Hepatitis Delta Treatment
- Vir Bio Reports Q3 2026 Financial Results and Gilead Collaboration Details
- Vir Biotechnology Projects Cash Runway into Second Half of 2028 Amid Key Clinical Milestones
- Vir Biotechnology, Inc. - 10-Q Filing
- Vir Biotechnology, Inc. - 8-K Filing
- Vir Biotechnology, Inc. - 8-K Filing
- Vir Biotechnology Licenses Technology to Gilead for Up to $1.9 Billion
- Vir Biotechnology, Inc. - 8-K Filing
- Vir Biotechnology, Inc. - 8-K Filing
- Vir Biotechnology Appoints David Liu as Chief Medical Officer
- Vir Biotechnology, Inc. - 8-K Filing
- Vir Biotechnology, Inc. - 8-K Filing
- Vir Biotechnology, Inc. - 8-K Filing
- Biotech Fund Superstring Capital Opens $6 Million Position in Vir Biotechnology
- Biotech Fund Superstring Capital Invests $5.82 Million in Vir Biotechnology Amid Significant Stock Rally
- SB Investment Advisers (UK) Ltd Sells $17M in Shares of Vir Biotechnology
- SB Investment Advisers Sells $17M Worth of Vir Biotechnology Shares
- Vir Biotechnology's Board Chairman Sells Shares
- Vir (VIR) Q1 2026 Earnings Call Highlights Partnership and Clinical Progress
- Vir Biotechnology (VIR) Reports 80.98% Year-to-Date Stock Growth
- Virgin Australia Adjusts Airfares and Forecasts Higher Fuel Costs Due to Middle East Conflict